Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vonoprazan Pregnancy Registry: An Observational Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring

NCT06660342 is registered in ClinicalTrials.gov with Phathom Pharmaceuticals, Inc. as lead sponsor.

NCT NCT06660342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06660342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vonoprazan Pregnancy Registry: An Observational Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
Lead sponsor
Phathom Pharmaceuticals, Inc.
Phase
Observational
Overall status
Recruiting
Start date
May 15, 2025
Completion date
September 30, 2034
Enrollment
728 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erosive esophagitis, heartburn, helicobacter pylori infection, symptomatic non-erosive gastroesophageal reflux disease